Skip to main content
. 2022 Aug 17;12:04053. doi: 10.7189/jogh.12.04053

Table 4.

Comparison of metabolic outcomes between the intervention and control groups

Outcome variables* Intervention (n = 145) Control (n = 160) P-values
BP (systolic), mean (SD)
107.6 (14.0)
104.7 (10.6)
0.031
BP (diastolic), mean (SD)
72.3 (10.5)
70.9 (9.1)
0.230
Elevated BP, n (%)
11 (7.6)
5 (3.1)
0.081
HbA1C, mean (SD)
5.3 (0.6)
5.2 (0.5)
0.093
>6.5mmol/l, n (%)
2 (1.4)
0
0.133
Total cholesterol, mean (SD)
4.86 (0.9)
4.79 (0.9)
0.527
>5.2mmol/l, n (%)
46 (32.2)
44 (27.7)
0.394
HDL, mean (SD)
1.45 (0.4)
1.43 (0.4)
0.632
<1.2mmol/l, n (%)
34 (23.8%)
45 (28.3%)
0.372
Triglycerides, mean (SD)
0.90 (0.5)
0.85 (0.4)
0.364
>1.7mmol/l, n (%) 11 (7.7) 6 (3.8) 0.140

BP – blood pressure, SD – standard deviation, HBA1c – haemoglobin A1c test, HDL – high-density lipoprotein

*Data were analysed by the null-hypothesis that there would be no difference between the intervention and control group; all variables were controlled for age-group by bootstrapping.